文献速递胸部肿瘤

年轻成人非小细胞肺癌的未满足需求:早期发病,晚期疾病

Early years, advanced disease: The unmet need in young adults with non-small cell lung cancer.
PubMed 文献 · Eur J Cancer · 2025-09-24

年轻组中IV期疾病更常见(66% vs 44%,p=0.005),且可靶向基因组改变如ALK易位更频繁(21% vs 2.2%,p<0.001),尤其在不吸烟患者中。年轻转移性NSCLC患者的总生存与年长组相似,但具有可靶向改变者生存改善。早期诊断仍是该亚组的关键未满足需求。

要点

  • 年轻成人肺癌患者中IV期疾病比例显著更高(66% vs 44%)。
  • 年轻组ALK易位发生率显著更高(21% vs 2.2%),尤其在不吸烟者中。
  • 年轻转移性NSCLC患者总生存与年长组相似,但靶向改变者生存改善。

核心结论

  • 早发性肺癌以晚期疾病、腺癌组织学和频繁可靶向基因组改变为特征,尤其在不吸烟患者中。
  • 早期诊断仍是该亚组患者的关键未满足医疗需求。

研究设计与样本

  • 回顾性队列研究,纳入2019至2023年在西德癌症中心诊断的肺癌患者。

主要发现

  • 年轻组不吸烟史比例更高(21% vs 6%,p<0.001)。
  • 年轻组腺癌(59% vs 49%)和NSCLC NOS(27% vs 8.2%)为优势组织学亚型(p<0.001)。
  • 年轻组IV期疾病更常见(66% vs 44%,p=0.005),区域淋巴结受累(N1-N3 79% vs 56.9%)和胸外淋巴结转移(38% vs 14%,p<0.001)更频繁。
  • 年轻组ALK易位频率更高(21% vs 2.2%,p<0.001)。
  • 年轻转移性NSCLC患者中位总生存与年长组相似,但具有可靶向改变者总生存改善。

临床怎么用

  • 对年轻肺癌患者应提高警惕,诊断时常为晚期,需关注可靶向基因组改变检测。
  • 尤其对不吸烟年轻患者,应积极进行分子检测以识别可靶向改变。

局限性

  • 回顾性单中心研究,样本量有限,年轻组仅56例。
  • 可能存在选择偏倚和信息偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Young adults are a minority of lung cancer (LC) patients, however, clinical presentation and cancer biology can differ. Here, we report the first German cohort study of young adults with LC. METHODS: We included patients diagnosed with LC between 2019 and 2023 at the West German Cancer Centre (University Medicine Essen) in this retrospective cohort study. For analysis of clinicogenomic baseline characteristics and overall survival (OS), patients were stratified by age at diagnosis into a young cohort (YC; n = 56, ≤45 years), an older cohort (OC; n = 2.682, >45 years) and analysed across age decades. RESULTS: 71 of 2.738 patients with LC (2.59 %) were ≤ 45 years old. 56/71 were diagnosed with NSCLC or SCLC. YC frequently reported no history of smoking (21 % vs. 6 %; p < 0.001). Among YC, adenocarcinoma (59 % vs. 49 %) and NSCLC not-otherwise-specified (NSCLC NOS; 27 % vs. 8.2 %) were the dominant histological subtypes (p < 0.001). Stage IV disease was significantly more common in YC (stage IV: 66 % vs. 44 %; p = 0.005) with more frequent regional lymph node involvement (N1-N3 79 % vs. 56.9 %) and extrathoracic lymph node metastases (38 % vs. 14 %; p < 0.001). Frequent targetable genomic alterations in YC included ALK translocations (21 % vs. 2.2 %; p < 0.001). YC with metastatic NSCLC had similar median OS compared to OC, although OS was improved in those with targetable alterations. CONCLUSION: Early-onset LC is characterized by advanced disease stage, adenocarcinoma histopathology and frequent targetable genomic alterations, especially in patients without a history of smoking. Early diagnosis remains a critical unmet medical need in this subgroup of patients.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Webendoerfer M, Wiesweg M, Winantea J, et al. Early years, advanced disease: The unmet need in young adults with non-small cell lung cancer. Eur J Cancer. 2025. PMID: 41033152. doi:10.1016/j.ejca.2025.116011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。